STOCK TITAN

Forma Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on August 13, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Forma Therapeutics Holdings (Nasdaq: FMTX) will release its second quarter 2021 financial results on August 13, 2021. An investment community conference call is scheduled for 8 a.m. ET on the same day to discuss these results and provide a business update. Interested investors can join the call via telephone or a live webcast on Forma's website.

Forma Therapeutics is dedicated to developing innovative therapies for rare hematologic diseases and cancers, utilizing their deep biological insights and clinical development capabilities.

Positive
  • Upcoming financial results may indicate strong business performance.
  • Management's commitment to investor communication through a scheduled conference call.
Negative
  • None.

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that it will release second quarter 2021 financial results Friday, Aug. 13, 2021. Forma management will host an investment community conference call at 8 a.m. Eastern Time, on Aug. 13, 2021, to discuss these financial results and provide a business update.

Investors may participate by dialing +1 (833) 301-1146 in the U.S. or Canada, or +1 (914) 987-7386 internationally, and by referring to Conference ID 9155938. A live webcast of the conference call will be available in the “News & Investors” section of Forma’s website at www.formatherapeutics.com.

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. For more information, please visit www.FormaTherapeutics.com or follow us on Twitter @FORMAInc and LinkedIn.

FAQ

When will Forma Therapeutics release its second quarter 2021 financial results?

Forma Therapeutics will release its second quarter 2021 financial results on August 13, 2021.

What time is the conference call for Forma Therapeutics' financial results?

The conference call for Forma Therapeutics' financial results is scheduled for 8 a.m. ET on August 13, 2021.

How can I participate in the Forma Therapeutics conference call?

Investors can participate in the Forma Therapeutics conference call by dialing +1 (833) 301-1146 in the U.S. or Canada, or +1 (914) 987-7386 internationally, using Conference ID 9155938.

Where can I find the live webcast of the Forma Therapeutics conference call?

The live webcast of the Forma Therapeutics conference call can be found in the 'News & Investors' section of Forma's website.

FMTX

NASDAQ:FMTX

FMTX Rankings

FMTX Latest News

FMTX Stock Data

1.01B
45.32M
5.13%
91.07%
2.66%
Biotechnology
Healthcare
Link
United States
Watertown